Alex's Lemonade Stand Foundation
Eligibility
- Must have MD, PhD, or MD/PhD (DO, MBBS or equivalent).
- Applicants may have research grants from other funding sources during the award period, but there must be clear documentation of mecahanisms to avoid scientific and budgetary overlap.
- Applicant must have research experience and a deep understanding of normal or malignant hematopoiesis and/or immunology.
Description
The RARE Grant is a two-year award designed to fund research that will lead to the development of therapies for patients with RUNX1-FPD that will either intercept the transition from a precancer state (clonal hematopoiesis) to MDS/AML or prevent blood cancer (before clonal hematopoiesis).
Keywords:
cancer, blood, RUNXI-FPD, therapies, precancer, hematopoiesis, immunology
Application due:
12/11/25
Award amount:
$250,000